CLDX:NASDAQ
Celldex Therapeutics Inc
$31.10
arrow_downward
-1.21%(-0.38) 1D
$31.55
arrow_upward
+1.45% (+0.45)bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 12 analysts giving stock ratings to CLDX in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for CLDX in the last 3 months.
Highest
Current $31.10
$100.00 (+221.54%)
Average
$64.58 (+107.65%)
Lowest
$28.00 (-9.97%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Thomas Smith Leerink Partners | Buy | Reiterated | $88.00 | +183% | 09/23/2026 |
Richard Law CFA Goldman Sachs | Hold | Maintained | $28.00 | -10% | 09/22/2026 |
Yatin Suneja Guggenheim | Buy | Reiterated | $100.00 | +221.5% | 09/22/2026 |
Edward Nash Canaccord Genuity | Buy | Reiterated | $60.00 | +92.9% | 09/23/2026 |
Alex Thompson CFA Stifel Nicolaus | Buy | Reiterated | $68.00 | +118.6% | 09/22/2026 |
Derek Archila Wells Fargo | Buy | Reiterated | $72.00 | +131.5% | 09/23/2026 |
Judah Frommer Morgan Stanley | Buy | Reiterated | $57.00 | +83.3% | 09/23/2026 |
Etzer Darout Barclays | Buy | Maintained | $53.00 | +70.4% | 09/22/2026 |
Joseph Pantginis H.C. Wainwright | Buy | Maintained | $64.00 | +105.8% | 09/23/2026 |
Sam Slutsky LifeSci Capital | Buy | Maintained | $56.00 | +80.1% | 09/20/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $68.00 | +118.6% | 08/07/2026 |
Kristen Kluska Cantor Fitzgerald | Buy | Reiterated | $61.00 | +96.1% | 08/06/2026 |
David Dai UBS | Buy | Maintained | $45.00 | +44.7% | 06/16/2026 |
Andy Chen Wolfe Research | Buy | Maintained | $44.00 | +41.5% | 06/14/2026 |
Yaron Werber TD Cowen | Buy | Maintained | - | - | 05/07/2026 |